Literature DB >> 32227068

National trends in age-standardized incidence and mortality rates of acute kidney injury in Peru.

Percy Herrera-Añazco1, Maycol Suker Ccorahua-Ríos2, Mirian Condori-Huaraka2, Yerika Huamanvilca-Yepez2, Elard Amaya3, Noé Atamari-Anahui1.   

Abstract

INTRODUCTION: Acute kidney injury (AKI) is a common disorder that causes high healthcare costs. There are limited epidemiological studies of this disorder in low- and middle-income countries. The aim of this study was to describe trends in the age-standardized incidence and mortality rates of AKI in Peru.
METHODS: We conducted an ecological study based on a secondary data sources of the basic cause of death from healthcare and death records obtained from establishments of the Ministry of Health of Peru for the period 2005-2016. The age-standardized incidence and mortality rates of AKI were described by region and trend effects were estimated by linear regression models.
RESULTS: During the period 2005-2016, 26,633 cases of AKI were reported nationwide. The age-standardized incidence rate of AKI per 100,000 people increased by 15.2%, from 10.5 (period 2005-2010) to 12.1 (period 2011-2016). During the period 2005-2016, 6,812 deaths due to AKI were reported, which represented 0.49% of all deaths reported for that period in Peru. The age-standardized mortality rate of AKI per 100,000 people decreased by 11.1%, from 2.7 (period 2005-2010) to 2.4 (period 2011-2016). The greatest incidence and mortality rates were observed in the age group older than 60 years.
CONCLUSIONS: During the study period, incidence of AKI increased and mortality decreased, with heterogeneous variations among regions.

Entities:  

Year:  2020        PMID: 32227068     DOI: 10.1590/2175-8239-jbn-2019-0132

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  1 in total

1.  Regional differences in Acute Kidney Injury incidence and mortality in developing countries: recent trends.

Authors:  Etienne Macedo; Ravindra L Mehta
Journal:  J Bras Nefrol       Date:  2020 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.